| The complex world of kidney microRNAs. | |
| | |
MedLine Citation:
|
PMID: 21799505 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
MicroRNAs are short noncoding RNAs that usually reduce translation of messenger RNAs. Changes in microRNA-192 (miR-192) are reported in states of renal fibrosis. New evidence supports a role for miR-192 and its target miR-200b/c in transforming growth factor-β1 regulation of its own expression and that of collagens in mesangial cells, with a possible role in diabetic nephropathy. As there is controversy on the role of these microRNAs in diabetic nephropathy, more work is needed. |
| | |
Authors:
|
Balakuntalam S Kasinath; Denis Feliers |
Related Documents
:
|
2615415 - Effect of zizyphus sativa leaves on blood glucose levels in normal and alloxan-diabetic... 11351355 - Antioxidant action of tinospora cordifolia root extract in alloxan diabetic rats. 2906565 - Sensitivity changes to inotropic agents in rabbit atria after chronic experimental diab... 7735235 - Effect of ophthalmic preservatives on serum concentration and local irritation of ocula... 9753305 - Prevalence of insulin resistance in metabolic disorders: the bruneck study. 12655415 - Insulin sensitivity and beta-cell secretion in thalassaemia major with secondary haemoc... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Kidney international Volume: 80 ISSN: 1523-1755 ISO Abbreviation: Kidney Int. Publication Date: 2011 Aug |
Date Detail:
|
Created Date: 2011-07-29 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0323470 Medline TA: Kidney Int Country: United States |
Other Details:
|
Languages: eng Pagination: 334-7 Citation Subset: IM |
Affiliation:
|
Department of Medicine, University of Texas Health Science Center, South Texas Veterans Health Care System, San Antonio, Texas, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Biomarker explorations in acute kidney injury: the journey continues.
Next Document: Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezom...